IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Novo Holdings A/S

Q2 2025 Holdings

Filed 2025-08-14 | 29 holdings | $1.4B | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Vanguard Index FDS(VTI)TOTAL STK MKT922908769$315.6M1,038,55022.3%
Brookfield Corp(BN)CL A LTD VT SH11271J107$144.2M2,330,83010.2%
Asml Holding N V(ASML)N Y REGISTRY SHSN07059210$132.9M165,8369.4%
Salesforce Inc(CRM)COM79466L302$90.0M330,1876.4%
Mirum Pharmaceuticals Inc(MIRM)COM604749101$76.3M1,500,0555.4%
Edgewise Therapeutics Inc(EWTX)COM28036F105$70.1M5,350,0005.0%
Insmed Inc(INSM)COM PAR $.01457669307$68.4M680,0004.8%
Recursion Pharmaceuticals in(RXRX)CL A75629V104$48.9M9,665,1283.5%
Crinetics Pharmaceuticals in(CRNX)COM22663K107$44.6M1,550,0003.1%
Alibaba Group Hldg LTD(BABA)SPONSORED ADS01609W102$42.2M372,3273.0%
Arrivent Biopharma Inc(AVBP)COM04272N102$40.8M1,872,1422.9%
Merus N VCOMN5749R100$39.5M750,0002.8%
Biomarin Pharmaceutical Inc(BMRN)COM09061G101$36.3M660,0002.6%
Blueprint Medicines Corp(2L9)COM09627Y109$34.0M264,9562.4%
Viridian Therapeutics Inc(VRDN)COM92790C104$33.3M2,380,0002.3%
Pharvaris N V(PHVS)COMN69605108$30.4M1,725,0002.1%
Vaxcyte Inc(PCVX)COM92243G108$29.8M916,1602.1%
Celldex Therapeutics Inc New(CLDX)COM NEW15117B202$24.4M1,200,0001.7%
Zenas Biopharma Inc(ZBIO)COM98937L105$21.8M2,250,0001.5%
Enliven Therapeutics Inc(ELVN)COM29337E102$21.8M1,084,4321.5%
Apogee Therapeutics Inc(APGE)COM03770N101$19.5M449,3921.4%
Ceribell Inc(CBLL)COM15678C102$16.9M900,0001.2%
Valneva SE(VALN)SPONSORED ADS92025Y103$13.5M2,375,0001.0%
4D Molecular Therapeutics in(FDMT)COM35104E100$7.4M2,000,0000.5%
IO Biotech Inc(IOBT)COM449778109$4.7M3,354,4490.3%
Lanzatech Global IncCOM51655R101$4.3M15,814,8450.3%
Marqeta Inc(MQ)CLASS A COM57142B104$2.6M441,5580.2%
Abcellera Biologics Inc(ABCL)COM00288U106$2.2M652,5290.2%
Galecto Inc(GLTO)COM NEW36322Q206$340.7K99,9130.0%